Sonus Pharmaceuticals
Sonus Pharmaceuticals, Inc., established in 1991 and based in Bothell, Washington, initially focused on developing innovative cancer therapies. After merging with OncoGenex Technologies to form OncoGenex Pharmaceuticals, the Sonus Pharmaceuticals name now represents a platform dedicated to providing reviews and ratings of mail-order pharmacies. Managed by healthcare experts, it aims to create a trusted global online pharmacy platform, emphasizing authoritative, evidence-based content and minimal commercial influence.
Industries
Nr. of Employees
small (1-50)
Sonus Pharmaceuticals
Bothell, Washington, United States, North America
Products
Camptothecin‑class investigational anticancer agent
An investigational camptothecin‑class small molecule developed as an anticancer candidate in preclinical and early clinical evaluation.
IGFBP5‑directed investigational agent
An investigational inhibitor directed at insulin‑like growth factor‑binding protein 5 developed for prostate cancer indications.
Lipophilic paclitaxel formulation (parenteral emulsion)
A lipophilic formulation of paclitaxel developed for metastatic breast cancer with clinical trial experience evaluating an alternative delivery approach.
Fluorocarbon emulsion formulation platform
Development of fluorocarbon emulsion products for imaging contrast and potential oxygen‑carrying therapeutic applications with preclinical and clinical evaluation experience.
TOCOSOL Paclitaxel
A vitamin E-based nanoemulsion formulation of the chemotherapeutic agent paclitaxel designed to replace traditional solvents like Cremophor EL and ethanol.
Camptothecin‑class investigational anticancer agent
An investigational camptothecin‑class small molecule developed as an anticancer candidate in preclinical and early clinical evaluation.
IGFBP5‑directed investigational agent
An investigational inhibitor directed at insulin‑like growth factor‑binding protein 5 developed for prostate cancer indications.
Lipophilic paclitaxel formulation (parenteral emulsion)
A lipophilic formulation of paclitaxel developed for metastatic breast cancer with clinical trial experience evaluating an alternative delivery approach.
Fluorocarbon emulsion formulation platform
Development of fluorocarbon emulsion products for imaging contrast and potential oxygen‑carrying therapeutic applications with preclinical and clinical evaluation experience.
TOCOSOL Paclitaxel
A vitamin E-based nanoemulsion formulation of the chemotherapeutic agent paclitaxel designed to replace traditional solvents like Cremophor EL and ethanol.
Services
Editorial reviews and assessments of online pharmacies covering legitimacy, security, sourcing, ordering workflows and customer‑support characteristics.
Evidence‑based articles and patient experience reports on sexual health, medication mechanisms, adverse effects, alternative therapies and treatment access issues reviewed by pharmacy and clinical experts.
Reports covering prescription verification, refill workflows, shipping methods, payment systems, medication sourcing and counterfeit risk for internet pharmacy services.
Summaries of evidence and expert opinion on the physiological effects of vasodilatory therapies in athletic performance and related anti‑doping policy considerations.
Editorial reviews and assessments of online pharmacies covering legitimacy, security, sourcing, ordering workflows and customer‑support characteristics.
Evidence‑based articles and patient experience reports on sexual health, medication mechanisms, adverse effects, alternative therapies and treatment access issues reviewed by pharmacy and clinical experts.
Reports covering prescription verification, refill workflows, shipping methods, payment systems, medication sourcing and counterfeit risk for internet pharmacy services.
Summaries of evidence and expert opinion on the physiological effects of vasodilatory therapies in athletic performance and related anti‑doping policy considerations.
Expertise Areas
- Oncology drug discovery
- Preclinical pharmacology and toxicology
- Clinical trial management and endpoint analysis
- Parenteral and emulsion formulation development
Key Technologies
- Fluorocarbon emulsion formulation
- Lipophilic anticancer formulation techniques
- Preclinical pharmacology assays
- Clinical trial statistical analysis